Cargando…
Morbidity and mortality of women and men with intellectual and developmental disabilities newly initiating antipsychotic drugs
BACKGROUND: While up to 45% of individuals with intellectual and developmental disabilities (IDD) have a comorbid psychiatric disorder, and antipsychotics are commonly prescribed, gender differences in the safety of antipsychotics have rarely been studied in this population. AIMS: To compare men and...
Autores principales: | Vigod, Simone N., Lunsky, Yona, Cobigo, Virginie, Wilton, Andrew S., Somerton, Sarah, Seitz, Dallas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal College of Psychiatrists
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998937/ https://www.ncbi.nlm.nih.gov/pubmed/27703773 http://dx.doi.org/10.1192/bjpo.bp.116.002691 |
Ejemplares similares
-
Antipsychotic initiation among adults with intellectual and developmental disabilities in Ontario: a population-based cohort study
por: Gomes, Tara, et al.
Publicado: (2019) -
Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities
por: Lunsky, Yona, et al.
Publicado: (2017) -
Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
por: Stogios, Nicolette, et al.
Publicado: (2023) -
Uptake of Colorectal Cancer Screening among Ontarians with Intellectual and Developmental Disabilities
por: Ouellette-Kuntz, Hélène, et al.
Publicado: (2015) -
Substance-related and addictive disorders among adults with intellectual and developmental disabilities (IDD): an Ontario population cohort study
por: Lin, Elizabeth, et al.
Publicado: (2016)